Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.
The post Choosing between antipsychotics to reduce the risk of breast cancer in women with schizophrenia appeared first on National Elf Service.